FIVE PRIME THERAPEUTICS INC 4
4 · FIVE PRIME THERAPEUTICS INC · Filed Aug 29, 2016
Insider Transaction Report
Form 4
Baker Kevin Paul
SVP, Development Sciences
Transactions
- Award
Common Stock
2016-08-25+7,500→ 82,500 total
Footnotes (1)
- [F1]Represents shares of restricted stock, which will vest according to the following schedule: one-third (1/3) of the restricted stock will vest on each of September 1, 2017, 2018 and 2019.